RUNX1异型在血小板-巨核细胞中不同调节RUNX1和向基因:与临床心血管事件的关联
Liying Guan1, Deepak Voora2, Rachel Myers3
1Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
bioRxiv : the preprint server for biology
|July 1, 2024
概括
RUNX1异型B和C不同调节基因表达和自身的产生. 这些异型与心血管疾病的急性事件有关,RUNX1C可能会提供保护.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 造血转录因子RUNX1 (与Runt相关的转录因子1) 存在于B和C异型,由不同的促进体产生.
- 在巨核细胞和血小板内的自调和下游基因控制中,RUNX1异型的特定作用仍然在很大程度上未被描述.
研究的目的:
- 阐明RUNX1异型B和C对RUNX1基因表达及其向基因的调节机制.
- 研究RUNX1异型及其向基因与心血管疾病 (CVD) 中急性事件的关联.
主要方法:
- 研究涉及到来自健康志愿者的巨核细胞HEL细胞,RUNX1-null HeLa细胞和血小板.
- 采用了染色体免疫沉, luciferase 记者测定和 RNA 测序.
- 在心血管疾病患者中,RUNX1目标基因与急性事件之间进行了关联分析.
主要成果:
- RUNX1异型B和C的RUNX1促进体 (P1和P2) 具有差异性结合和调节.
- 在HEL细胞中RUNX1B和RUNX1C的过度表达改变了其他RUNX1异型和基因 (例如MYL9,F13A1) 的表达.
- 血小板中的RUNX1异型表达与特定的基因表达模式相关,某些RUNX1标与急性心血管疾病事件有关.
结论:
- RUNX1异型B和C表现出不同的自我调节功能和对下游基因的差异控制.
- 观察到的RUNX1异型的差异调节与心血管疾病患者的急性事件有关.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


